Search Form

U.S.- CHINA | ECONOMIC and SECURITY REVIEW COMMISSION

U.S.-China Economic AND Security Review Commission

Potential Health & Safety Impacts from Pharmaceuticals and Supplements Containing Chinese-Sourced Raw Ingredients

Related Content

• Research

Illicit Fentanyl from China: An Evolving Global Operation

The issue brief examines the evolution of China’s role in global illicit fentanyl trade. Read More
• Research

China’s Healthcare System: Addressing Capacity Shortfalls…

The novel coronavirus (COVID-19) pandemic has brought unprecedented attention to challenges in…

 Read More
• Research

Beijing’s Deadly Game: Consequences of Excluding Taiwan…

This report includes the following key findings:

 Read More
• Research

Cascading Economic Impacts of the COVID-19 Outbreak in China

The U.S.-China Economic and Security Review Commission released a staff research report…

 Read More